Search results
AMD STOPPER Offers New Hope to Sufferers of Age-Related Macular Degeneration | Healthcare Dive
Healthcare Dive· 2 days agoFearful of losing all of his central vision to the gradual blinding effects of Age-Related Macular Degeneration (AMD), a California-based researcher with ...
Breakthrough Study Reveals Somavedic Device's Potential Impact on Wet AMD Patients
Char-Koosta News· 2 days agoHospital in Ústí nad Labem in the Czech Republic, have unveiled groundbreaking findings from a study showcasing the effectiveness of the Somavedic device in supporting individuals with wet age-related ...
The murky, unregulated world of anti-ageing stem cell therapy
The Telegraph via Yahoo News· 12 hours agoStem cells are the new focal point of the rich and famous with Hollywood A-listers reportedly...
Byooviz dosage: Form, strength, when to use, and more
Medical News Today· 7 days agoByooviz (ranibizumab-nuna) is a brand-name drug prescribed for certain eye conditions in adults. It...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 8 hours agoStargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034 | DelveInsight PR Newswire LAS VEGAS, April 24, 2024 The expected launch of potential therapies may increase the Stargardt disease market size in the coming years, assisted by an
Toppling Goliath Brewing Co. partners with BREWS for BLiNDNESS
The Hannibal Courier-Post· 7 days agoToppling Goliath Brewing Co. has partnered with Iowa based Non-Profit BREWS for BLiNDNESS to support...
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
Morningstar· 7 days ago(NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet ...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 days agoMoreover, its planned launch of aflibercept—for patients living with wet macular degeneration—could be a potentially significant biosimilar opportunity,...
Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2...
Morningstar· 6 days agoGA affects approximately 1 million people in the United States alone.
I Can See Clearly Now: Eye Care for Seniors Begins at 50 - The Baltimore Times
Baltimore Times· 6 days agoIf you can recall the Johnny Nash 70’s chart-topping hit “I Can See Clearly Now” or grew up watching...